- Bio-Rad to Report Third-Quarter 2020 Financial Results, Thursday, October 29, 2020
- Biodesix to Provide COVID-19 Testing for Colorado State University Campus
- The United States Court of Appeals for the Federal Circuit Affirms That 10x Genomics Willfully Infringed Bio-Rad U.S. Patent and Upholds Lower Court’s Award of Damages
- Bio-Rad Reports Second-Quarter 2020 Financial Results
As of last trade
Bio Rad Laboratories Inc (BIO:NYQ) traded at 557.50, -2.84% below its 52-week high of 573.80, set on Oct 13, 2020.
309.38Mar 23 2020573.80Oct 13 2020
Markit short selling activity
|Market cap||16.53bn USD|
|EPS (TTM)||64.46 |
Data delayed at least 15 minutes, as of Oct 21 2020 18:55 BST.